Plain-English translation of NCT07483658 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether men with prostate cancer that has returned after surgery can be treated safely with a shorter radiation therapy schedule. Right now, doctors give radiation over 5 weeks, but researchers want to know if 4 weeks works just as well while causing fewer side effects like urinary or bowel problems. This could help men complete treatment faster and get back to their normal lives.
Prostate cancer comes back in many men after surgery, and radiation helps control it—but the best way to deliver the radiation is still being figured out. A shorter treatment schedule could save time and improve quality of life, but doctors need to prove it's safe before recommending it widely.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive radiation therapy either over 4 weeks (20 sessions) or 5 weeks (25 sessions). You'll visit the treatment center 4–5 times per week for your radiation sessions, and you may also receive hormone therapy for 6–24 months. The study will follow you for up to 10 years to monitor whether the cancer stays controlled and to track any side effects on your urinary, bowel, and sexual health.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
Canada